Chairs
- Myung-Ju Ahn (Seoul, Korea, Republic of)
- Martin Reck (Grosshansdorf, Germany)
Is Osimertinib the best single agent if 1st line?
Speakers
- Myung-Ju Ahn (Seoul, Korea, Republic of)
Should chemotherapy be combined upfront with EGFR TKI?
Speakers
- Ross Soo (Singapore, Singapore)
Is a combination of anti-angiogenic with EFGR TKI a new standard
Speakers
- Martin Reck (Grosshansdorf, Germany)
Do immune check point work in EGFR TKI?
Speakers
- Edward B. Garon (Santa Monica, CA, United States of America)
In a multiline setting, what is the best sequencing?
Speakers
- Enriqueta Felip (Barcelona, Spain)
Conclusions
Speakers
- Myung-Ju Ahn (Seoul, Korea, Republic of)
Live Q&A
Speakers
- Myung-Ju Ahn (Seoul, Korea, Republic of)
- Martin Reck (Grosshansdorf, Germany)